Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension

Journal of the American College of Cardiology

Volumn 31, Issue 1, 1998, Pages 202-208

  Nagaya, Noritoshi ^a   Nishikimi, Toshio ^a   Okano, Yoshiaki ^a   Uematsu, Masaaki ^a   Satoh, Toru ^a   Kyotani, Shingo ^a   Kuribayashi, Sachio ^a   Hamada, Seiki ^a   Kakishita, Mikio ^a   Nakanishi, Norifumi ^a   Takamiya, Makoto ^a   Kunieda, Takeyoshi ^a   Matsuo, Hisayuki ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NITRIC OXIDE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMORAL VEIN; HEART ATRIUM SEPTUM DEFECT; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE OVERLOAD; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG RESISTANCE; MALE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 17144452791     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00452-X     Document Type: Article

References (30)

1. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 332:1988;78-81.
2. Mukoyama M, Nakao K, Saito Y, et al. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans evidence for an exquisite dual natriuretic peptide system, ANP and BNP . J Clin Invest. 87:1991;1402-1412.
3. Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 84:1991;1581-1588.
4. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:1994;195-203.
5. Nishikimi T, Yoshihara F, Morimoto A, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension. 28:1996;22-30.
6. Hill NS, Klinger JR, Warburton RR, Pietras L, Wrenn DS. Brain natriuretic peptide possible role in the modulation of hypoxic pulmonary hypertension . Am J Physiol. 266:1994;L308-L315.
7. Nootens M, Kaufmann E, Rector T, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension relation to hemodynamic variables and endothelin levels . J Am Coll Cardiol. 26:1995;1581-1585.
8. Reiter SJ, Rumberger JA, Feiring AJ, Stanford W, Marcus ML. Precision of measurements of right and left ventricular volume by cine computed tomography. Circulation. 74:1986;890-900.
9. Hajduczok ZD, Weiss RM, Stanford W, Marcus ML. Determination of right ventricular mass in humans and dogs with ultrafast cardiac computed tomography. Circulation. 82:1990;202-212.
10. Antman EM, Marsh JD, Green LH, Grossman W. Blood oxygen measurements in the assessment of intracardiac left to right shunts a critical appraisal of methodology . Am J Cardiol. 46:1980;265-271.
11. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension a national prospective study . Ann Intern Med. 107:1987;216-223.
12. D'Alonzo GE, Bower JS, Dantzker DR. Differentiation of patients with primary and thromboembolic pulmonary hypertension. Chest. 85:1984;457-461.
13. Fishmann AJ, Moser KM, Fedullo PF. Perfusion lung scan vs pulmonary angiography in evaluation of suspected primary pulmonary hypertension. Chest. 84:1983;679-683.
14. Tada H, Shimizu W, Ohe T, et al. Usefulness of electron-beam computed tomography in arrhythmogenic right ventricular dysplasia relationship to electrophysiological abnormalities and left ventricular involvement . Circulation. 94:1996;437-444.
15. Kunieda T, Kyotani S, Satoh T, Okano Y, Nakanishi N, Hukushima T. A new computer built-in NO inhalation device using mass flow controller and its clinical application [in Japanese]. Kokyu to Junkan. 44:1996;513-519.
16. Weir EK, Rubin LJ, Ayres SM, et al. The acute administration of vasodilators in primary pulmonary hypertension experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension . Am Dev Respir Dis. 140:1989;1623-1630.
17. Hosoda K, Nakao K, Mukoyama M, et al. Expression of brain natriuretic peptide gene in human heart production in the ventricle . Hypertension. 17:1991;1152-1156.
18. Lang CC, Coutie WJ, Struthers AD, Dhillon DP, Winter JH, Lipworth BJ. Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci. 83:1992;529-533.
19. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 338:1991;1173-1174.
20. Kangawa K, Matsuo H. Purification and complete amino acid sequence of ∂-human atrial natriuretic polypeptide. Biochem Biophys Res Commun. 118:1984;131-139.
21. Yandle TG, Richards AM, Nicholls MG, Cuneo R, Espiner EA, Livesey JH. Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci. 38:1986;1827-1833.
22. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Framptom C. Renal, endocrine and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 76:1993;91-96.
23. Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. Am J Respir Crit Care Med. 151:1995;384-389.
24. Raffy O, Azarian R, Brenot F, et al. Clinical significance of the pulmonary vasodilator respons during short-term infusion of prostacyclin in primary pulmonary hypertension. Circulation. 93:1996;484-488.
25. Montorsi P, Tonolo G, Polonia J, Hepburn D, Richard M. Correlates of plasma atrial natriuretic factor in health and hypertension. Hypertension. 10:1987;570-576.
26. Hirata Y, Ishii M, Fukui K, et al. A possible physiological role of atrial natriuretic peptide in body fluid volume regulation. J Cardiovasc Pharmacol. 13:(Suppl 6):1989;S63-S68.
27. Rascher W, Tulassay T, Rang RE. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet. 2:1985;303-305.
28. Solomon LR, Atherton JC, Bobinski H, Green R. Effect of posture on plasma immunoreactive atrial natriuretic polypeptide concentrations in man. Clin Sci. 71:1986;299-305.
29. Nishikimi T, Kohno M, Itagane H, et al. Influence of exercise on plasma atrial natriuretic factor levels in patients with myocardial infarction. Am Heart J. 115:1988;753-760.
30. Pidgeon GB, Richards AM, Nicholls MG, Espiner EA, Yandle TG, Frampton C. Differing metabolism and bioactivity of atrial and brain natriuretic peptides in essential hypertension. Hypertension. 27:1996;906-913.